Literature DB >> 26601784

The multifaceted functions of C/EBPα in normal and malignant haematopoiesis.

E Ohlsson1,2,3, M B Schuster1,2,3, M Hasemann1,2,3, B T Porse1,2,3.   

Abstract

The process of blood formation, haematopoiesis, depends upon a small number of haematopoietic stem cells (HSCs) that reside in the bone marrow. Differentiation of HSCs is characterised by decreased expression of genes associated with self-renewal accompanied by a stepwise activation of genes promoting differentiation. Lineage branching is further directed by groups of cooperating and counteracting genes forming complex networks of lineage-specific transcription factors. Imbalances in such networks can result in blockage of differentiation, lineage reprogramming and malignant transformation. CCAAT/enhancer-binding protein-α (C/EBPα) was originally identified 30 years ago as a transcription factor that binds both promoter and enhancer regions. Most of the early work focused on the role of C/EBPα in regulating transcriptional processes as well as on its functions in key differentiation processes during liver, adipogenic and haematopoietic development. Specifically, C/EBPα was shown to control differentiation by its ability to coordinate transcriptional output with cell cycle progression. Later, its role as an important tumour suppressor, mainly in acute myeloid leukaemia (AML), was recognised and has been the focus of intense studies by a number of investigators. More recent work has revisited the role of C/EBPα in normal haematopoiesis, especially its function in HSCs, and also started to provide more mechanistic insights into its role in normal and malignant haematopoiesis. In particular, the differential actions of C/EBPα isoforms, as well as its importance in chromatin remodelling and cellular reprogramming, are beginning to be elucidated. Finally, recent work has also shed light on the dichotomous function of C/EBPα in AML by demonstrating its ability to act as both a tumour suppressor and promoter. In the present review, we will summarise the current knowledge on the functions of C/EBPα during normal and malignant haematopoiesis with special emphasis on the recent work.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26601784     DOI: 10.1038/leu.2015.324

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  102 in total

1.  Ras signaling enhances the activity of C/EBP alpha to induce granulocytic differentiation by phosphorylation of serine 248.

Authors:  Gerhard Behre; Sheo M Singh; Huaitian Liu; Laura T Bortolin; Max Christopeit; Hanna S Radomska; Janki Rangatia; Wolfgang Hiddemann; Alan D Friedman; Daniel G Tenen
Journal:  J Biol Chem       Date:  2002-04-26       Impact factor: 5.157

2.  Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation.

Authors:  Hanno Hock; Melanie J Hamblen; Heather M Rooke; David Traver; Roderick T Bronson; Scott Cameron; Stuart H Orkin
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

3.  C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4.

Authors:  H Wang; P Iakova; M Wilde; A Welm; T Goode; W J Roesler; N A Timchenko
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

Review 4.  Enhancer function: new insights into the regulation of tissue-specific gene expression.

Authors:  Chin-Tong Ong; Victor G Corces
Journal:  Nat Rev Genet       Date:  2011-03-01       Impact factor: 53.242

Review 5.  The role of mutations in epigenetic regulators in myeloid malignancies.

Authors:  Alan H Shih; Omar Abdel-Wahab; Jay P Patel; Ross L Levine
Journal:  Nat Rev Cancer       Date:  2012-08-17       Impact factor: 60.716

6.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

7.  Mutation of CEBPA in familial acute myeloid leukemia.

Authors:  Matthew L Smith; Jamie D Cavenagh; T Andrew Lister; Jude Fitzgibbon
Journal:  N Engl J Med       Date:  2004-12-02       Impact factor: 91.245

8.  AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.

Authors:  T Okuda; J van Deursen; S W Hiebert; G Grosveld; J R Downing
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

9.  Rapid and sensitive screening for CEBPA mutations in acute myeloid leukaemia.

Authors:  Tobias Benthaus; Friederike Schneider; Gudrun Mellert; Evelyn Zellmeier; Stephanie Schneider; Purvi M Kakadia; Wolfgang Hiddemann; Stefan K Bohlander; Michaela Feuring-Buske; Jan Braess; Karsten Spiekermann; Annika Dufour
Journal:  Br J Haematol       Date:  2008-08-24       Impact factor: 6.998

10.  Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia.

Authors:  Hong Zhang; Meritxell Alberich-Jorda; Giovanni Amabile; Henry Yang; Philipp B Staber; Annalisa Di Ruscio; Annalisa Diruscio; Robert S Welner; Alexander Ebralidze; Junyan Zhang; Elena Levantini; Véronique Lefebvre; Peter J M Valk; Ruud Delwel; Maarten Hoogenkamp; Claus Nerlov; Jörg Cammenga; Borja Saez; David T Scadden; Constanze Bonifer; Min Ye; Daniel G Tenen
Journal:  Cancer Cell       Date:  2013-10-31       Impact factor: 31.743

View more
  29 in total

1.  C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1.

Authors:  Wei Chen; Guochun Zhu; Jun Tang; Hou-De Zhou; Yi-Ping Li
Journal:  J Pathol       Date:  2018-01-29       Impact factor: 7.996

Review 2.  Role of RUNX1 in hematological malignancies.

Authors:  Raman Sood; Yasuhiko Kamikubo; Paul Liu
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

Review 3.  The Ontogeny of a Neutrophil: Mechanisms of Granulopoiesis and Homeostasis.

Authors:  Shelley M Lawrence; Ross Corriden; Victor Nizet
Journal:  Microbiol Mol Biol Rev       Date:  2018-02-07       Impact factor: 11.056

4.  Monocyte-Specific Knockout of C/ebpα Results in Osteopetrosis Phenotype, Blocks Bone Loss in Ovariectomized Mice, and Reveals an Important Function of C/ebpα in Osteoclast Differentiation and Function.

Authors:  Wei Chen; Guochun Zhu; Joel Jules; Diep Nguyen; Yi-Ping Li
Journal:  J Bone Miner Res       Date:  2018-01-26       Impact factor: 6.741

5.  An integrated approach to elucidate signaling pathways of dioscin-induced apoptosis, energy metabolism and differentiation in acute myeloid leukemia.

Authors:  She-Hung Chan; Pi-Hui Liang; Jih-Hwa Guh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-03-28       Impact factor: 3.000

6.  Transcription factor-driven coordination of cell cycle exit and lineage-specification in vivo during granulocytic differentiation : In memoriam Professor Niels Borregaard.

Authors:  Kim Theilgaard-Mönch; Sachin Pundhir; Kristian Reckzeh; Jinyu Su; Marta Tapia; Benjamin Furtwängler; Johan Jendholm; Janus Schou Jakobsen; Marie Sigurd Hasemann; Kasper Jermiin Knudsen; Jack Bernard Cowland; Anna Fossum; Erwin Schoof; Mikkel Bruhn Schuster; Bo T Porse
Journal:  Nat Commun       Date:  2022-06-23       Impact factor: 17.694

Review 7.  The complexity of neutrophils in health and disease: Focus on cancer.

Authors:  Silvia Carnevale; Somayehsadat Ghasemi; Anna Rigatelli; Sebastien Jaillon
Journal:  Semin Immunol       Date:  2020-09-18       Impact factor: 11.130

8.  Destabilization of AETFC through C/EBPα-mediated repression of LYL1 contributes to t(8;21) leukemic cell differentiation.

Authors:  Meng-Meng Zhang; Na Liu; Yuan-Liang Zhang; Bowen Rong; Xiao-Lin Wang; Chun-Hui Xu; Yin-Yin Xie; Shuhong Shen; Jiang Zhu; Stephen D Nimer; Zhu Chen; Sai-Juan Chen; Robert G Roeder; Fei Lan; Lan Wang; Qiu-Hua Huang; Xiao-Jian Sun
Journal:  Leukemia       Date:  2019-02-12       Impact factor: 11.528

9.  CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group.

Authors:  Katherine Tarlock; Adam J Lamble; Yi-Cheng Wang; Robert B Gerbing; Rhonda E Ries; Michael R Loken; Lisa Eidenschink Brodersen; Laura Pardo; Amanda Leonti; Jenny L Smith; Tiffany A Hylkema; William G Woods; Todd M Cooper; E Anders Kolb; Alan S Gamis; Richard Aplenc; Todd A Alonzo; Soheil Meshinchi
Journal:  Blood       Date:  2021-09-30       Impact factor: 25.476

Review 10.  How transcription circuits explore alternative architectures while maintaining overall circuit output.

Authors:  Chiraj K Dalal; Alexander D Johnson
Journal:  Genes Dev       Date:  2017-07-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.